Foundation Medicine (FMI) Tops Q1 EPS by 8c

Foundation Medicine (NASDAQ: FMI) reported Q1 EPS of ($1.02), $0.08 better than the analyst estimate of ($1.10). Revenue for the quarter came in at $52.8 million versus the consensus estimate of $44.92 million.

GUIDANCE:

Foundation Medicine sees FY2018 revenue of $200-220 million, versus the consensus of $212.3 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M